“…113 The success rate was higher for phaco/iStent compared with phaco/ECP (75.3% vs. 54.4%), while adding iStent to phaco/ECP led to higher success rates in the early postoperative period. 113 However, it's important to consider the larger proportion of severe glaucoma cases in the phaco/ECP group when interpreting the results. Ferguson et al observed that combining phacoemulsification, ECP, and iStent (phaco/ECP/iStent) resulted in significantly greater IOP reduction compared with phacoemulsification with only iStent implantation for mild to moderate glaucoma patients.…”
“…Deitz et al conducted a comparative analysis of 349 eyes that underwent phaco/iStent. phaco/ECP, or phaco/iStent/ECP 113 . The success rate was higher for phaco/iStent compared with phaco/ECP (75.3% vs. 54.4%), while adding iStent to phaco/ECP led to higher success rates in the early postoperative period 113 .…”
“…phaco/ECP, or phaco/iStent/ECP 113 . The success rate was higher for phaco/iStent compared with phaco/ECP (75.3% vs. 54.4%), while adding iStent to phaco/ECP led to higher success rates in the early postoperative period 113 . However, it’s important to consider the larger proportion of severe glaucoma cases in the phaco/ECP group when interpreting the results.…”
“…113 The success rate was higher for phaco/iStent compared with phaco/ECP (75.3% vs. 54.4%), while adding iStent to phaco/ECP led to higher success rates in the early postoperative period. 113 However, it's important to consider the larger proportion of severe glaucoma cases in the phaco/ECP group when interpreting the results. Ferguson et al observed that combining phacoemulsification, ECP, and iStent (phaco/ECP/iStent) resulted in significantly greater IOP reduction compared with phacoemulsification with only iStent implantation for mild to moderate glaucoma patients.…”
“…Deitz et al conducted a comparative analysis of 349 eyes that underwent phaco/iStent. phaco/ECP, or phaco/iStent/ECP 113 . The success rate was higher for phaco/iStent compared with phaco/ECP (75.3% vs. 54.4%), while adding iStent to phaco/ECP led to higher success rates in the early postoperative period 113 .…”
“…phaco/ECP, or phaco/iStent/ECP 113 . The success rate was higher for phaco/iStent compared with phaco/ECP (75.3% vs. 54.4%), while adding iStent to phaco/ECP led to higher success rates in the early postoperative period 113 . However, it’s important to consider the larger proportion of severe glaucoma cases in the phaco/ECP group when interpreting the results.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.